Year archive

Immuron Ltd — 2017 filings

All 142 regulatory filings released by Immuron Ltd (IMRN) in 2017, sourced directly from the official regulator.

142 Filings

2017 Period

2017 filings (142)

Filing	Released	Lang
Appendix 3Y - Change of Director's Interest Notice (PA) 2 pages 44.9KB Regulatory Filings	2017-12-21	English
Appendix 3Y - Change of Director's Interest Notice (SA) 2 pages 45.1KB Regulatory Filings	2017-12-21	English
Form 604 - Change in Substantial Shareholding (Grandlodge) 3 pages 46.3KB Regulatory Filings	2017-12-21	English
6-K Foreign Filer Report	2017-12-14	English
Appendix 3B 10 pages 258.4KB Regulatory Filings	2017-12-13	English
6-K Foreign Filer Report	2017-11-22	English
Van Leeuwenhoeck Institute Updates Immuron Research Coverage 2 pages 187.9KB Regulatory Filings	2017-11-21	English
6-K Foreign Filer Report	2017-11-14	English
Immuron Granted US Patent for NASH Treatment 2 pages 219.5KB Regulatory Filings	2017-11-13	English
Results of 2017 Annual General Meeting 1 page 284.5 Regulatory Filings	2017-11-12	English
FORM 6-K Foreign Filer Report	2017-11-09	English
6-K Foreign Filer Report	2017-11-08	English
Immuron Successfully Completes NASH Phase II Clinical Study 3 pages 224.5KB Regulatory Filings	2017-11-08	English
Travelan Experiences Strong Q1 FY2018 Sales Growth 2 pages 337.7KB Regulatory Filings	2017-11-07	English
424B3 Prospectus	2017-11-02	English
20-F Annual Report FY 2017	2017-11-02	English
Immuron Lodges Form 20F USA Annual Report 146 pages 2.0MB Regulatory Filings	2017-11-02	English
NT 20-F Regulatory Filings	2017-10-31	English
Notice of Annual General Meeting & Proxy Form 22 pages 1.2MB Regulatory Filings	2017-10-17	English
6-K Foreign Filer Report	2017-10-10	English
Appendix 3Y - Change of Director's Interest Notice (PA) 2 pages 126.3KB Regulatory Filings	2017-10-09	English
6-K Foreign Filer Report	2017-09-29	English
Annual Report 82 pages 12.5MB Regulatory Filings	2017-09-27	English
Appendix 4G 10 pages 414.1KB Regulatory Filings	2017-09-27	English
Corporate Governance Statement 8 pages 537.8KB Regulatory Filings	2017-09-27	English
FORM 6-K Foreign Filer Report	2017-09-13	English
6-K Foreign Filer Report	2017-09-11	English
Appendix 3Y - Change of Director's Interest Notice (DP) 2 pages 499.7KB Regulatory Filings	2017-09-10	English
6-K Foreign Filer Report	2017-09-08	English
Form 605 - Ceasing to be Substantial Shareholder (Retzos) 2 pages 589.3KB Regulatory Filings	2017-09-07	English
FORM 6-K Foreign Filer Report	2017-08-31	English
Appendix 4E Preliminary Final Report (30 June 2017) 21 pages 1.1MB Regulatory Filings	2017-08-30	English
6-K Foreign Filer Report	2017-08-28	English
Appendix 3Y - Change of Director's Interest Notice (PA) 2 pages 499.8KB Regulatory Filings	2017-08-27	English
Immuron Opens Clinical Site to Commence C.Diff CDI Study 3 pages 976.4KB Regulatory Filings	2017-08-27	English
6-K Foreign Filer Report	2017-08-17	English
Updated Immuron Securities Trading Policy 7 pages 127.5KB Regulatory Filings	2017-08-16	English
6-K Foreign Filer Report	2017-08-15	English
Immuron Commences US Non-Deal Institutional Investor Roadshw 43 pages 5.2MB Regulatory Filings	2017-08-14	English
Appendix 3Y - Change of Director's Interest Notice (PA) 2 pages 43.0KB Regulatory Filings	2017-08-14	English
Immuron Approved to Commence Clinical Study in C.Difficile 3 pages 118.8KB Regulatory Filings	2017-08-08	English
6-K Foreign Filer Report	2017-08-08	English
Appendix 3Y - Change of Director's Interest Notice (PA) 2 pages 370.5KB Regulatory Filings	2017-08-07	English
Immuron to Present C.difficile Data at ClostPath 2017 Confer 3 pages 360.1KB Regulatory Filings	2017-08-07	English
6-K Foreign Filer Report	2017-08-07	English
Immuron Presents NASH Interim-Results at BioShares Conferenc 12 pages 1.5MB Regulatory Filings	2017-08-06	English
424B3 Prospectus	2017-08-03	English
FORM 6-K Foreign Filer Report	2017-08-03	English
Immuron Announces Management Changes 2 pages 341.0KB Regulatory Filings	2017-08-02	English
6-K Foreign Filer Report	2017-07-31	English
Appendix 3B 11 pages 710.8KB Regulatory Filings	2017-07-27	English
6-K Foreign Filer Report	2017-07-13	English
Success of NASH Phase II Interim Analysis Explained Further 4 pages 375.9KB Regulatory Filings	2017-07-12	English
Regulatory Filings 2017 Regulatory Filings	2017-07-11	English
Regulatory Filings 2017 Regulatory Filings	2017-07-11	English
Regulatory Filings 2017 Regulatory Filings	2017-07-11	English
FORM 6-K Foreign Filer Report	2017-07-10	English
NASH PhaseII Interim Analysis Reveals Improved Liver Enzymes 3 pages 351.2KB Regulatory Filings	2017-07-09	English
6-K Foreign Filer Report	2017-07-05	English
Appendix 3Y - Change of Director's Interest Notice (RS) 2 pages 43.1KB Regulatory Filings	2017-07-02	English
Pre-Clinical C. difficile Infection Results Paper Published 3 pages 357.4KB Regulatory Filings	2017-07-02	English
FORM 6-K Foreign Filer Report	2017-06-27	English
Change of address 2 pages 226.8KB Regulatory Filings	2017-06-25	English
Major Shareholding Notification 2017 Major Shareholding Notification	2017-06-22	English
6-K Foreign Filer Report	2017-06-22	English
Appendix 3B - Issuance of Options (ESOP) 11 pages 714.8KB Regulatory Filings	2017-06-22	English
6-K Foreign Filer Report	2017-06-21	English
Change of Director's Interest Notice 2 pages 382.7KB Regulatory Filings	2017-06-19	English
Change of Director's Interest Notice 2 pages 372.9KB Regulatory Filings	2017-06-19	English
Change of Director's Interest Notice 2 pages 386.4KB Regulatory Filings	2017-06-19	English
Change in substantial holding 3 pages 292.7KB Regulatory Filings	2017-06-19	English
Change in substantial holding 3 pages 275.9KB Regulatory Filings	2017-06-19	English
Ceasing to be a substantial holder 2 pages 769.4KB Regulatory Filings	2017-06-19	English
Appendix 3B - Allotment of NASDAQ Listing 11 pages 717.0KB Regulatory Filings	2017-06-15	English
FORM 6-K Foreign Filer Report	2017-06-14	English
424B4 Prospectus	2017-06-13	English
Regulatory Filings 2017 Regulatory Filings	2017-06-12	English
424B4 Prospectus	2017-06-09	English
Regulatory Filings 2017 Regulatory Filings	2017-06-09	English
FORM F-1 MEF Regulatory Filings	2017-06-09	English
AUTO-GENERATED PAPER DOCUMENT Regulatory Filings	2017-06-08	English
IMC Prices US IPO and NASDAQ Listing Raising USD$6.1M 3 pages 1.2MB Regulatory Filings	2017-06-08	English
Trading Halt 2 pages 306.0KB Regulatory Filings	2017-06-07	English
Regulatory Filings 2017 Regulatory Filings	2017-06-06	English
Regulatory Filings 2017 Regulatory Filings	2017-06-06	English
Regulatory Filings 2017 Regulatory Filings	2017-06-01	English
Regulatory Filings 2017 Regulatory Filings	2017-06-01	English
Travelan Increases Industry Presence - Conf & Sales Update 3 pages 1.2MB Regulatory Filings	2017-06-01	English
NASDAQ Listing on Hold Pending NASH Interim Analysis Results 3 pages 1.1MB Regulatory Filings	2017-05-31	English
Immuron Secures $1.5M R&D Cash Advance Loan Funding 3 pages 1.1MB Regulatory Filings	2017-05-31	English
Trading Halt 2 pages 305.7KB Regulatory Filings	2017-05-29	English
Regulatory Filings 2017 Regulatory Filings	2017-05-26	English
Regulatory Filings 2017 Regulatory Filings	2017-05-26	English
Regulatory Filings 2017 Regulatory Filings	2017-05-26	English
F-1/A Regulatory Filings	2017-05-26	English
Regulatory Filings 2017 Regulatory Filings	2017-05-25	English
Regulatory Filings 2017 Regulatory Filings	2017-05-25	English
8-A12B Regulatory Filings	2017-05-25	English
Regulatory Filings 2017 Regulatory Filings	2017-05-25	English
Regulatory Filings 2017 Regulatory Filings	2017-05-25	English
Regulatory Filings 2017 Regulatory Filings	2017-05-25	English
F-1/A Regulatory Filings	2017-05-25	English
Regulatory Filings 2017 Regulatory Filings	2017-05-24	English
F-1/A Regulatory Filings	2017-05-24	English
FWP Regulatory Filings	2017-05-22	English
F-1/A Regulatory Filings	2017-05-22	English
Regulatory Filings 2017 Regulatory Filings	2017-05-22	English
Regulatory Filings 2017 Regulatory Filings	2017-05-19	English
IMC Expands Agreement with US Army-3 Additional Therapeutics 3 pages 1.2MB Regulatory Filings	2017-05-15	English
Regulatory Filings 2017 Regulatory Filings	2017-05-11	English
Regulatory Filings 2017 Regulatory Filings	2017-05-10	English
Completion of Manufacturing of Drug Product for C-Diff Trial 3 pages 1.2MB Regulatory Filings	2017-05-09	English
FWP Regulatory Filings	2017-05-08	English
Immuron Files Amended Form F-1 and New Investor Presentation 2 pages 1.1MB Regulatory Filings	2017-05-08	English
IMC Form F1 - US Registration Statement (Prelim. Prospectus) 200 pages 1.1MB Regulatory Filings	2017-05-08	English
Immuron - New Investor Corporate Presentation (May 2017) 39 pages 7.0MB Regulatory Filings	2017-05-08	English
Regulatory Filings 2017 Regulatory Filings	2017-05-08	English
F-1/A Regulatory Filings	2017-05-08	English
Form 603 - Initial Substantial Shareholder (Authentics) 3 pages 104.2KB Regulatory Filings	2017-05-04	English
Form 604 - Change in Substantial Shareholding (Authentics) 3 pages 106.3KB Regulatory Filings	2017-05-04	English
F-1/A Regulatory Filings	2017-04-28	English
Regulatory Filings 2017 Regulatory Filings	2017-04-26	English
Positive Results of IMM-124E in Acute Colitis Studies 3 pages 1.3MB Regulatory Filings	2017-04-17	English
Immuron Update on Listing - Process Proceeding as Planned 4 pages 108.4KB Regulatory Filings	2017-04-10	English
Immuron Update on US Listing - Proceeding as Planned 3 pages 424.9KB Regulatory Filings	2017-04-10	English
Immuron Files Amended Form F-1 with the SEC 206 pages 2.1MB Regulatory Filings	2017-04-09	English
Regulatory Filings 2017 Regulatory Filings	2017-04-08	English
F-1/A Regulatory Filings	2017-04-08	English
Director Appointment - Prof. Ravi Savarirayan 3 pages 256.6KB Regulatory Filings	2017-04-06	English
Close of Recruitment of Phase II NASH Trial 3 pages 428.9KB Regulatory Filings	2017-04-05	English
Appendix 4D - Half Year Report and Accounts - Dec 2016 24 pages 1.2MB Regulatory Filings	2017-02-27	English
Regulatory Filings 2017 Regulatory Filings	2017-02-23	English
Immuron Completes Phase II NASH Clinical Trial Recruitment 3 pages 1.1MB Regulatory Filings	2017-02-19	English
Regulatory Filings 2017 Regulatory Filings	2017-02-08	English
F-1/A Regulatory Filings	2017-02-08	English
Immuron Files Amended Form F-1 with the SEC 190 pages 1.7MB Regulatory Filings	2017-02-08	English
First Patient in Pediatric Fatty-Liver Phase II Trial 2 pages 436.7KB Regulatory Filings	2017-02-05	English
Regulatory Filings 2017 Regulatory Filings	2017-01-18	English
NASH MOA Study commences with SanyalBio & Duke University 3 pages 469.8KB Regulatory Filings	2017-01-18	English
European/US Analyst - Immuron Moving to Forefront in NASH 2 pages 87.9KB Regulatory Filings	2017-01-17	English
Gilead Pays $100M NASH Related Milestone to Phenex 2 pages 114.5KB Regulatory Filings	2017-01-08	English
JNJ, BMS and Novartis Complete NASH Asset Transactions 2 pages 102.7KB Regulatory Filings	2017-01-05	English

Filings by year

2026 23 filings
2025 142 filings
2024 106 filings
2023 79 filings
2022 70 filings
2021 57 filings
2020 118 filings
2019 134 filings
2018 92 filings
2017 142 filings
2016 59 filings
2015 47 filings
2014 44 filings
2013 57 filings
2012 76 filings
2011 49 filings
2010 47 filings
2009 61 filings
2008 46 filings
2007 45 filings
2006 27 filings
2005 28 filings
2004 30 filings
2003 19 filings
2002 4 filings